Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Rothenberg

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|March 27, 2019
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-<i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy VolunteersMelicent Peck, Michael E Rothenberg, Rong Deng, et al.
Gastroenterology|March 1, 2015
Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric GlandsMichael Sigal, Michael E Rothenberg, Catriona Y Logan, et al.
Gastroenterology|February 16, 2012
Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in miceMichael E Rothenberg, Ysbrand Nusse, Tomer Kalisky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative ColitisSilvio Danese, Michael E Rothenberg, Jeremy J Lim, et al.
Nature Cell Biology|November 3, 2014
A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesisFerenc A Scheeren, Angera H Kuo, Linda J van Weele, et al.
Nature Biotechnology|November 15, 2011
Single-cell dissection of transcriptional heterogeneity in human colon tumorsPiero Dalerba, Tomer Kalisky, Debashis Sahoo, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Annals of Clinical and Translational Neurology|January 11, 2022
A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALSJonathan S Katz, Jeffrey D Rothstein, Merit E Cudkowicz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Antimicrobial Agents and Chemotherapy|March 27, 2019
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-<i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy VolunteersMelicent Peck, Michael E Rothenberg, Rong Deng, et al.
Gastroenterology|March 1, 2015
Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric GlandsMichael Sigal, Michael E Rothenberg, Catriona Y Logan, et al.
Gastroenterology|February 16, 2012
Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in miceMichael E Rothenberg, Ysbrand Nusse, Tomer Kalisky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative ColitisSilvio Danese, Michael E Rothenberg, Jeremy J Lim, et al.
Nature Cell Biology|November 3, 2014
A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesisFerenc A Scheeren, Angera H Kuo, Linda J van Weele, et al.
Nature Biotechnology|November 15, 2011
Single-cell dissection of transcriptional heterogeneity in human colon tumorsPiero Dalerba, Tomer Kalisky, Debashis Sahoo, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Annals of Clinical and Translational Neurology|January 11, 2022
A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALSJonathan S Katz, Jeffrey D Rothstein, Merit E Cudkowicz, et al.
Pageof 3